Sign up for the Race/Related Newsletter join a deep and provocative exploration of race identity and society with New York Times journalists. Get it sent to your inbox.
Cipla announced that Cipla EU, wholly owned subsidiary of the company in UK, has agreed to acquire an additional 19.16% stake in Cipla Maroc SA, joint venture and subsidiary of Cipla EU in Morocco. Upon completion of the transaction, Cipla EU will hold 79.16% stake in the joint venture company and balance 20.84% stake will be held by Cooper Pharma.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
